United States
Germany
Japan
United Kingdom
China
MEK2 C-Term Antibody FITC
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
Human IgG (H&L) Antibody Fluorescein Conjugated
| Applications | IF: 1:1,000 - 1:5,000 FC: 1:500 - 1:2,500 FLISA: 1:10,000 - 1:50,000 |
| Reactivities | Human |
| Conjugation | FITC |
MEK2 C-Term Antibody FITC
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat |
MEK2 N-Term Antibody FITC
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat |
MEK1 C-Term Antibody FITC
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat |
MEK2 N-Term Antibody FITC
| Applications | ELISA, WB |
| Reactivities | Human, Mouse, Rat |
CNY 9,630.00
5周
Human IgA (Secretory component) mouse monoclonal antibody, clone NI 194-4 (A89-039), FITC
| Applications | To identify the presence of free or bound Secretory component in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques Immunofluorescence staining techinqiues. General Recommended Dilutions: Histochemical Use: from 1/10 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
CNY 3,410.00
5周
Human IgG (Fc heavy chain specific) mouse monoclonal antibody, clone EM-07, FITC
| Applications | Direct Immunofluorescence analysis: 2-5 µg/ml. |
| Reactivities | Human |
| Conjugation | FITC |
HLA Class II DR mouse monoclonal antibody, clone MEM-12, FITC
| Applications | FC |
| Reactivities | Human |
Human Lambda Light Chain mouse monoclonal antibody, clone 4C2, FITC
| Applications | FC |
| Reactivities | Human |
HLA Class II DR rat monoclonal antibody, clone YD1/63.4.10, FITC
| Applications | FC |
| Reactivities | Human |
CD10 (MME) mouse monoclonal antibody, clone MEM-78, FITC
| Applications | FC |
| Reactivities | Human |
CD55 / DAF mouse monoclonal antibody, clone MEM-118, FITC
| Applications | FC |
| Reactivities | Human, Primate |
HLA Class II DR + DP mouse monoclonal antibody, clone MEM-136, FITC
| Applications | FC |
| Reactivities | Human |
CD21 (CR2) mouse monoclonal antibody, clone LB21, FITC
| Applications | FC |
| Reactivities | Human |
活动过滤器
优化搜索结果
Target Symbol
- PTPRC (8)
- CD19 (7)
- CD4 (6)
- CD45 (6)
- ITGAM (6)
- CD14 (5)
- CD3E (5)
- CD44 (5)
- CD8A (5)
- FAS (5)
- CD34 (4)
- CD5 (4)
- CD59 (4)
- ENG (4)
- FCGR3A (4)
- KRT18 (4)
- MAP2K2 (4)
- MAPK1 (4)
- MME (4)
- MS4A1 (4)
- TFRC (4)
- CD40 (3)
- CD62E (3)
- CD7 (3)
- CD9 (3)
- CR2 (3)
- EGFR (3)
- GYPA (3)
- HLA-G (3)
- ICAM1 (3)
- IFNG (3)
- ITGAE (3)
- ITGB2 (3)
- PECAM1 (3)
- SELL (3)
- SPN (3)
- TP53 (3)
- ALB (2)
- BCL3 (2)
- C1QA (2)
- CD13 (2)
- CD151 (2)
- CD16 (2)
- CD1A (2)
- CD2 (2)
- CD200 (2)
- CD21 (2)
- CD22 (2)
- CD24 (2)
- CD28 (2)
- CD36 (2)
- CD55 (2)
- CD79A (2)
- CD79B (2)
- CD81 (2)
- CD99 (2)
- CEACAM5 (2)
- CYTOKERATIN 8 (2)
- DCR1 (2)
- EPCAM (2)
- FCGR2A (2)
- GLYCOPHORIN A (2)
- GP9 (2)
- HLA-B (2)
- IL2 (2)
- IL2RA (2)
- INTERFERON GAMMA (2)
- ITGA2B (2)
- ITGB1 (2)
- ITGB3 (2)
- KLRD1 (2)
- LACTOFERRIN (2)
- LAMP1 (2)
- MAP2K1 (2)
- MPO (2)
- NCAM1 (2)
- PDPN (2)
- PRTN3 (2)
- S100A1 (2)
- TEK (2)
- TG (2)
- THY1 (2)
- TLR2 (2)
- TLR4 (2)
- TNFRSF1B (2)
- VASP (2)
- VCAM1 (2)
- VIM (2)
- ADGRE3 (1)
- AFP (1)
- AKT1 (1)
- AKT3 (1)
- ANPEP (1)
- ASGR1 (1)
- B2M (1)
- B7-2 (1)
- BCL2 (1)
- BCL2L1 (1)
- C-MYC (1)
- C3 (1)
Antibody Hosts
Isotypes
Clonalities
Families
- Druggable Genome (95)
- Transmembrane (83)
- ES Cell Differentiation/IPS (42)
- Secreted Protein (26)
- Adult stem cells (12)
- Protease (7)
- Phosphatase (6)
- Cancer stem cells (5)
- Embryonic stem cells (5)
- Transcription Factors (5)
- Induced pluripotent stem cells (3)
- Protein Kinase (2)
- Stem cell - Pluripotency (2)
- Stem cell relevant signaling - DSL/Notch pathway (2)
- Stem cell relevant signaling - JAK/STAT signaling pathway (2)
- GPCR (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Cell adhesion molecules (CAMs) (39)
- Hematopoietic cell lineage (36)
- T cell receptor signaling pathway (22)
- Primary immunodeficiency (19)
- Cytokine-cytokine receptor interaction (17)
- Natural killer cell mediated cytotoxicity (16)
- Systemic lupus erythematosus (13)
- Allograft rejection (11)
- Complement and coagulation cascades (9)
- Fc gamma R-mediated phagocytosis (9)
- Type I diabetes mellitus (9)
- Autoimmune thyroid disease (8)
- Graft-versus-host disease (8)
- Jak-STAT signaling pathway (8)
- Viral myocarditis (8)
- Antigen processing and presentation (7)
- B cell receptor signaling pathway (7)
- Apoptosis (6)
- Pathways in cancer (6)
- Toll-like receptor signaling pathway (6)
- Focal adhesion (5)
- ECM-receptor interaction (4)
- Leukocyte transendothelial migration (4)
- Regulation of actin cytoskeleton (4)
- Small cell lung cancer (4)
- TGF-beta signaling pathway (4)
- Asthma (3)
- Bladder cancer (3)
- Colorectal cancer (3)
- Endocytosis (3)
- Endometrial cancer (3)
- ErbB signaling pathway (3)
- MAPK signaling pathway (3)
- Prostate cancer (3)
- RIG-I-like receptor signaling pathway (3)
- Adherens junction (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Calcium signaling pathway (2)
- Dilated cardiomyopathy (2)
- Glutathione metabolism (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Metabolic pathways (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathogenic Escherichia coli infection (2)
- Prion diseases (2)
- Proteasome (2)
- Regulation of autophagy (2)
- Renin-angiotensin system (2)
- Acute myeloid leukemia (1)
- Adipocytokine signaling pathway (1)
- Alzheimer's disease (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Axon guidance (1)
- Cell cycle (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Cytosolic DNA-sensing pathway (1)
- Dorso-ventral axis formation (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Fc epsilon RI signaling pathway (1)
- Gap junction (1)
- Glioma (1)
- GnRH signaling pathway (1)
- Lysosome (1)
- Melanoma (1)
- NOD-like receptor signaling pathway (1)
- Neuroactive ligand-receptor interaction (1)
- Neurotrophin signaling pathway (1)
- Thyroid cancer (1)
- Type II diabetes mellitus (1)
- Wnt signaling pathway (1)
